These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8447168)

  • 21. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand.
    Lolekha S; Warachit B; Hirunyachote A; Bowonkiratikachorn P; West DJ; Poerschke G
    Vaccine; 2002 Nov; 20(31-32):3739-43. PubMed ID: 12399203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simplified schedule to integrate the hepatitis B vaccine into an expanded program of immunization in endemic countries.
    Lee CY; Lee PI; Huang LM; Chen JM; Chang MH
    J Pediatr; 1997 Jun; 130(6):981-6. PubMed ID: 9202623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth.
    Cooper A; Yusuf H; Rodewald L; Malik T; Pollard R; Pickering L
    Pediatrics; 2001 Dec; 108(6):E98. PubMed ID: 11731625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
    Huu TN; Phuong NT; Toan NT; Thang HV
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
    Arístegui J; Dal-Ré R; Díez-Delgado J; Marés J; Casanovas JM; García-Corbeira P; De Frutos E; Van Esso D; Verdaguer J; De la Flor J; Moraga F; Boceta R; García-Martínez JA
    Vaccine; 2003 Sep; 21(25-26):3593-600. PubMed ID: 12922087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of hepatitis B vaccination into rural African primary health care programmes.
    Schoub BD; Johnson S; McAnerney JM; Blackburn N; Kew MC; McCutcheon JP; Carlier ND
    BMJ; 1991 Feb; 302(6772):313-6. PubMed ID: 1825799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization.
    Grosheide PM; del Canho R; Heijtink RA; Nuijten AS; Zwijnenberg J; Bänffer JR; Wladimiroff YW; Botman MJ; Mazel JA; de Gast GC
    Am J Dis Child; 1993 Dec; 147(12):1316-20. PubMed ID: 8249953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers.
    Hsu HM; Chen DS; Chuang CH; Lu JC; Jwo DM; Lee CC; Lu HC; Cheng SH; Wang YF; Wang CY
    JAMA; 1988 Oct; 260(15):2231-5. PubMed ID: 2971827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.
    Gatchalian SR; Ramakrishnan G; Bock HL; Lefevre I; Jacquet JM
    Hum Vaccin; 2010 Aug; 6(8):664-72. PubMed ID: 20657177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased seroprevalence of hepatitis B in dental personnel necessitates awareness of revised pediatric hepatitis B vaccine recommendations.
    Wisnom CJ; Lee RJ
    J Public Health Dent; 1993; 53(4):231-4. PubMed ID: 8258785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New acellular pertussis-containing paediatric combined vaccines.
    Pines E; Barrand M; Fabre P; Salomon H; Blondeau C; Wood SC; Hoffenbach A
    Vaccine; 1999 Mar; 17(13-14):1650-6. PubMed ID: 10194818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The response of hepatitis B vaccination on seronegative adults with different vaccination schedules.
    Yao J; Li J; Chen Y; Shan H; Dai XW; Yang LN; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Wang B; Xie TS; Li Q
    Hum Vaccin Immunother; 2015; 11(5):1102-7. PubMed ID: 25621975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
    Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
    Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers.
    Lee AW; Jordanov E; Boisnard F; Marshall GS
    Expert Rev Vaccines; 2017 Feb; 16(2):85-92. PubMed ID: 27996332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.
    Tregnaghi M; López P; Rocha C; Rivera L; David MP; Rüttimann R; Schuerman L
    Rev Panam Salud Publica; 2006 Mar; 19(3):179-88. PubMed ID: 16640847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.